Skip to main content

Advertisement

Log in

A case of menetrier’s disease associated with protein-losing gastropathy and abnormal serum complement profile

  • Case Report
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

A 44-year-old man with Menetrier’s disease associated with protein-losing gastropathy and with abnormal serum complement profile is reported. He was treated by an antifibrinolytic compound tranexamic acid (trans-AMCHA) since he was found to have elevated fibrinolytic activity in the biopsied gastric mucosa. The therapy brought his serum protein from 3.8g/dl to 5.6g/dl, however could not reduce his mucosal disorder. Substitution of a placebo for trans-AMCHA resulted in marked depression of his serum protein to 3.7g/dl. It was concluded that trans-AMCHA was effective in raising his serum protein to a certain extent but failed to block the vicious circle of “mucosal disorder”, “increased tissue fibrinolysis” and “hypoproteinemia” (Kondo, M. et al. Gastroenterology 70, 1045, 1976). Abnormal serum complement profile seen in this patient was found to be due to cold activation of the classical complement pathway (Kondo, M. et al. J. Immunol. 117, 486, 1976). Although no correlation between the phenomenon and Menetrier’s disease has been clarified yet, the appearance of wheezing as in asthma when exposed to cold suggested that cold activation of complement occurred in vivo and resulted in increasing of the vascular permeability in the lungs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Citrin Y, Sterling K, Halsted JA: Mechanism of hypoproteinemia associated with giant hypertrophy of gastric mucosa. New Engl J Med 257: 906–912, 1957

    Article  PubMed  CAS  Google Scholar 

  2. Gordon MN, Scaefer EJ, Finkel M: Treatment of protein-losing gastroenteropathy with atropine. Am J Gastroent 66: 535–539, 1976

    PubMed  CAS  Google Scholar 

  3. Kondo M, Bamba T, Hosokawa K, et al: Tissue plasmiogen activator in the pathogenesis of protein-losing gastroenteropathy. Gastroenterology 70: 1045–1047, 1976

    PubMed  CAS  Google Scholar 

  4. Kohler PF, TenBensei R: Serial Complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. Clin Exp Immunol 4: 191–202. 1964

    Google Scholar 

  5. Donaldson VM, Evans RR: A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C’l esterase. Am J Med 35: 37–44, 1963

    Article  PubMed  CAS  Google Scholar 

  6. Brown DL, Lachmann PJ: The behaviour of complement and platelets in lethal endotoxin shock in rabbits. Int Arch allergy 45: 193–205, 1973

    PubMed  CAS  Google Scholar 

  7. Inai S, Kitamura H, Fujita T et al: Differences between plasma and serum complement in patients with chronic liver disease. Clin Exp Immunol 25: 403–409, 1976

    PubMed  CAS  Google Scholar 

  8. Kondo M, Hosokawa K, Masuda M: Cold activation of complement. I. Presence of coagulation-related activator. J Immunol 117: 486–490, 1976

    PubMed  CAS  Google Scholar 

  9. Astrup T, Müllertz S: The fibrin plate method for estimating fibrinolytic activity. Arch biochem Biophys 40: 346–351, 1952

    Article  PubMed  CAS  Google Scholar 

  10. Kondo M, Nakanishi K, Bamba T et al: Experimental protein-losing gastroenteropathy. Role of Tissue plasminogen activator. Gastroenterology 71: 631–634, 1976

    PubMed  CAS  Google Scholar 

  11. Mayer MM: Mechanism of hemolysis by complement. In Ciba Foundation Symposium on Complement. Ed GEW Wolstenholme, J Knight pp 4–32. J & A Churcill Ltd 1965

  12. Colten HR, Borsos T, Rapp HJ: Titration of the first component of complement on a molecular basis: Suitability of IgM and unsuitability of IgG hemolysins assensitizer. Immunochem 6: 461–467, 1969

    Article  CAS  Google Scholar 

  13. Hoffman LG: Purification of the first and fourth components of guinea pig complement and studies on their mechanism of action. Thesis, School of Hygene and Public Health, Johns Hopkins University, Baltimore, Md 1960

    Google Scholar 

  14. Borsos T, Rapp HJ, Mayer MM: Studies on the second component of complement. I. The reaction between EAC’1,4 and C’2: evidence on the single site mechanism of immune hemolysis and determination of C’2 on a molecular basis. J Immunol 87: 310–325, 1961

    CAS  Google Scholar 

  15. Steinfeld JL, Davidson JD, Gordon RS, Jr, et al: Mechanism of hypoproteinemia in patients with regional enteritis, and ulcerative colitis. Am J Med 29: 405–415, 1960

    Article  PubMed  CAS  Google Scholar 

  16. Holman H, Nickel WF, Sleisenger MH: Hypoproteinemia antedating intestinal lesions, and possibly due to excessive serum protein loss into intestine. Am J Med 27: 963–975, 1959

    Article  PubMed  CAS  Google Scholar 

  17. Waldmann TA, Steinfeld JL, Dutcher TF, et al: Role of gastrointestinal system in “idiopathic hypoproteinemia”. Gastroenterology 41: 197–207, 1961

    PubMed  CAS  Google Scholar 

  18. Davidson JD, Waldmann TA, Goodman DS, et al: Protein-losing gastroenteropathy in congestive heart failure. Lancet 1: 899–902, 1961

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kondo, M., Nishibori, H., Ikezaki, M. et al. A case of menetrier’s disease associated with protein-losing gastropathy and abnormal serum complement profile. Gastroenterol Jpn 13, 297–302 (1978). https://doi.org/10.1007/BF02774053

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02774053

Key Words

Navigation